Can a Death Doula Support Someone with Cardiac Amyloidosis (ATTR)?
By CRYSTAL BAI •
The short answer: Yes. A death doula can support someone with cardiac amyloidosis (ATTR or AL) by helping navigate the complex intersection of heart failure, neuropathy, and amyloid disease, supporting treatment decisions about tafamidis and heart failure management, and providing compassionate presence through a disease that progresses despite newer therapies.
Can a Death Doula Support Someone with Cardiac Amyloidosis (ATTR)?
Cardiac amyloidosis — particularly ATTR (transthyretin) amyloidosis — is an increasingly recognized cause of heart failure in older adults, characterized by deposition of abnormal protein fibrils in the heart. Once poorly understood and untreatable, ATTR amyloidosis now has approved therapies (tafamidis, acoramidis), but the disease continues to progress and remains life-limiting for many patients.
ATTR Amyloidosis Disease Trajectory
Wild-type ATTR (wtATTR) affects older adults, predominantly men, causing progressive restrictive cardiomyopathy and heart failure. Hereditary ATTR involves pathogenic TTR variants and may cause both cardiac and neurological disease. Despite tafamidis, disease continues to progress in most patients, with median survival of 3–5 years from diagnosis in many series.
AL (Light Chain) Amyloidosis
AL amyloidosis is a plasma cell dyscrasia where amyloid deposits affect multiple organs — heart, kidneys, liver, nerves. Cardiac AL amyloidosis carries a particularly poor prognosis — with median survival of less than a year in severe cardiac involvement without treatment. A death doula may be urgently needed after an AL diagnosis.
End-of-Life Decisions in Cardiac Amyloidosis
Key decisions include: whether to continue tafamidis or other therapies; device management (ICD deactivation, diuretic management); heart transplant evaluation for select patients; and when to transition to hospice. A death doula helps patients and families navigate these decisions with their values at the center.
Frequently Asked Questions
What is ATTR amyloidosis?
ATTR amyloidosis is caused by deposits of misfolded transthyretin protein in organs, most commonly the heart and nerves. It comes in two forms: wild-type ATTR (occurring in older adults without a genetic mutation) and hereditary ATTR (caused by pathogenic TTR variants, often in specific ethnic groups including Black Americans for Val122Ile).
Is cardiac amyloidosis more common in Black Americans?
Val122Ile ATTR amyloidosis — the most common hereditary ATTR variant — is present in approximately 3–4% of African Americans and is a significant cause of heart failure in older Black adults. This variant is much less common in white Americans.
When is hospice appropriate for cardiac amyloidosis?
Hospice may be appropriate for cardiac amyloidosis patients with advanced heart failure (NYHA Class III-IV) who have not responded to or declined treatment, particularly when prognosis is estimated at six months or less. Palliative cardiology programs can help facilitate hospice referral.
Can a death doula help with ICD management in amyloidosis?
Yes. Death doulas do not make clinical decisions, but they help patients and families understand and process the decision about ICD deactivation — which is particularly important at end of life when ICD shocks can prolong dying and cause distress. They support the emotional weight of this decision.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.